Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure.

Heart Failure Reviews
Mihai GheorghiadeJaved Butler

Abstract

Although patients hospitalized with heart failure have relatively low in-hospital mortality, the post-discharge rehospitalization and mortality rates remain high despite advances in treatment. Most patients admitted for heart failure have normal or high blood pressure, but 15-25 % have low systolic blood pressure with or without signs and/or symptoms of hypoperfusion. All pharmacological agents known to improve the prognosis of patients with heart failure also reduce blood pressure, and this limits their use in patients with heart failure and low blood pressure (HF-LBP). However, patients with HF-LBP have much higher in-hospital and post-discharge mortality. In these patients, a conceptually important therapeutic target is to improve cardiac output in order to alleviate signs of hypoperfusion. Accordingly, the majority of these patients will require an inotrope as cardiac dysfunction is the cause of their low cardiac output. However, the short-term use of currently available inotropes has been associated with further decreases in blood pressure and increases in heart rate, myocardial oxygen consumption and arrhythmias. Agents that improve cardiac contractility without this undesirable effects should be developed. To the best of...Continue Reading

References

Dec 16, 1976·The New England Journal of Medicine·J S ForresterH J Swan
Dec 1, 1992·Journal of the American College of Cardiology·T KonoS Goldstein
Apr 15, 1999·The New England Journal of Medicine·R J GoldbergJ M Gore
Jan 15, 2000·Heart & Lung : the Journal of Critical Care·M GheorghiadeR O Bonow
Aug 10, 2000·European Journal of Heart Failure·L W Stevenson
Mar 28, 2002·JAMA : the Journal of the American Medical Association·Michael S CuffeUNKNOWN Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigato
Jul 23, 2002·Lancet·F FollathUNKNOWN Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study
Jul 26, 2002·Journal of Cardiac Failure·Stephen S GottliebHarlan M Krumholz
Jan 9, 2003·JAMA : the Journal of the American Medical Association·Margaret M RedfieldRichard J Rodeheffer
Mar 26, 2003·Journal of the American College of Cardiology·G Michael FelkerUNKNOWN OPTIME-CHF Investigators
Nov 20, 2003·JAMA : the Journal of the American Medical Association·Douglas S LeeJack V Tu
Jan 13, 2004·Journal of the American College of Cardiology·Daniel E FormanHarlan M Krumholz
Apr 29, 2004·JAMA : the Journal of the American Medical Association·Mihai GheorghiadeUNKNOWN Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure (ACTIV in CHF) Investigators
Dec 16, 2004·Journal of Cardiac Failure·G Michael FelkerChristopher M O'Connor
Feb 3, 2005·JAMA : the Journal of the American Medical Association·Gregg C FonarowUNKNOWN ADHERE Scientific Advisory Committee, Study Group, and Investigators
Sep 27, 2005·The American Journal of Cardiology·Markku S Nieminen, Veli-Pekka Harjola
Sep 27, 2005·The American Journal of Cardiology·Mihai GheorghiadeChristopher M O'Connor
Sep 27, 2005·The American Journal of Cardiology·Melike BayramMihai Gheorghiade
Oct 4, 2005·The American Journal of Cardiology·Mihai GheorghiadeGary S Francis
Dec 21, 2005·Circulation·Mihai GheorghiadeUNKNOWN International Working Group on Acute Heart Failure Syndromes
Apr 11, 2006·European Heart Journal·Luigi TavazziUNKNOWN Italian survey on Acute Heart Failure Investigators
Sep 13, 2006·Circulation·Mihai GheorghiadeRobert O Bonow
Nov 9, 2006·JAMA : the Journal of the American Medical Association·Mihai GheorghiadeUNKNOWN OPTIMIZE-HF Investigators and Coordinators
Nov 23, 2006·The American Journal of Medicine·Mihai GheorghiadeJohn Burnett
Jan 24, 2007·The American Journal of Cardiology·Mihai Gheorghiade, Hani N Sabbah
Jan 24, 2007·The American Journal of Cardiology·David D ShinMihai Gheorghiade
Mar 27, 2007·JAMA : the Journal of the American Medical Association·Marvin A KonstamUNKNOWN Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators
May 3, 2007·JAMA : the Journal of the American Medical Association·Alexandre MebazaaUNKNOWN SURVIVE Investigators

❮ Previous
Next ❯

Citations

Jul 23, 2014·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Andrea MortaraUNKNOWN IN-HF Outcome Investigators
May 15, 2013·Journal of Cardiac Failure·Muthiah Vaduganathan, Mihai Gheorghiade
Jul 3, 2013·Heart Failure Clinics·Muthiah VaduganathanJaved Butler
Jun 26, 2014·European Journal of Heart Failure·Michel KomajdaUNKNOWN SHIFT Investigators
Apr 14, 2016·Revista clínica española·N Manito LoriteÒ Miró Andreu
Jun 11, 2015·Stem Cells and Development·Sharon Del Bem Velloso de MoraisHelio Cesar Salgado
May 20, 2016·Current Hypertension Reports·Kamila LachowskaDagmara Hering
Jan 16, 2018·European Journal of Heart Failure·Hector O Ventura, Mandeep R Mehra
Aug 9, 2017·European Journal of Heart Failure·Andrew P Ambrosy, Mihai Gheorghiade
Jan 25, 2020·European Journal of Heart Failure·Valentina CarubelliUNKNOWN Istaroxime ADHF Trial Group
Oct 1, 2013·Expert Review of Cardiovascular Therapy·Peter S PangSanjiv J Shah
Jun 20, 2017·European Journal of Heart Failure·Aleksandra Nikolovska VukadinovićMichael Böhm
Jan 5, 2021·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Xiaojing ChenMichael Fu
Mar 9, 2021·Circulation. Heart Failure·Xavier RosselloUNKNOWN ICA-SEMES Research Group*
May 14, 2021·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Amr AbdinMichael Böhm
Feb 8, 2019·La Presse médicale·Emmanuelle MagnyCarmelo Lafuente-Lafuente

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Related Papers

Journal of the American College of Cardiology
Nirat BeoharMihai Gheorghiade
British Journal of Hospital Medicine
N R BannerS Rahman-Haley
© 2021 Meta ULC. All rights reserved